Perry Sternberg
InvestorVenture Partner at Visionary Ventures
About
Brings over 30 years of commercial leadership and 15 years in eye care across Novartis, Bausch & Lomb, and Shire, including leading the launch of Xiidra. Was part of the leadership team behind Shire's sale to Takeda.
Colleagues at Visionary Ventures
Bill Carpou
Investor at Visionary Ventures
Bob Avery
Investor at Visionary Ventures
Daniel Gil
Venture Partner at Visionary Ventures
Dick Lindstrom
Investor at Visionary Ventures
Dr. Bob Avery
Investment Committee at Visionary Ventures
Dr. Dick Lindstrom
Investment Committee at Visionary Ventures
Dr. Ehsan Sadri
Investment Committee at Visionary Ventures
Dr. Toby Tyson
Investment Committee at Visionary Ventures